Konstantinos Xynos - Nov 18, 2024 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role: Chief Medical Officer
Signature: /s/ Shawn Glidden, attorney-in-fact
Stock symbol: REPL
Transactions as of: Nov 18, 2024
Transactions value $: -$78,112
Form type: 4
Date filed: 11/20/2024, 09:31 PM
Previous filing: Jun 10, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REPL	Common Stock	Sale	-$78.1K	-7.25K	-6.19%	$10.78	110K	Nov 18, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person.

Content

Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person.